Artificial Intelligence (AI) In Biopharmaceuticals Industry Anticipated to Expand at 33% CAGR During the Forecast Period
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Artificial Intelligence (AI) In Biopharmaceuticals Market By 2029?
The artificial intelligence (AI) in biopharmaceuticals market has experienced rapid expansion recently. Its size is projected to increase from $1.59 billion in 2024 to $2.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 32.2%. This historical growth has been driven by several factors, including advancements in computational power, the biomedical data explosion, the precision medicine paradigm, and regulatory support and guidance.
The artificial intelligence (AI) in biopharmaceuticals market is anticipated to undergo significant growth over the next few years, with its size expected to ascend to $6.58 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 33.0%. This expansion during the forecast period is primarily driven by breakthroughs in computational biology, the incorporation of multi-modal data, the convergence of AI and life sciences, supportive regulatory frameworks, and the implementation of ethical and fair AI principles. Noteworthy trends during this time encompass the integration of multi-omics data, AI-powered drug design and discovery, the acceptance of explainable AI by regulators, ongoing technological advancements, developments in regulation, and the identification of new opportunities.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp
Which Industry Drivers Are Expected To Accelerate The Artificial Intelligence (AI) In Biopharmaceuticals Market From 2025 To 2029?
The increasing incidence of chronic illnesses is anticipated to fuel the expansion of artificial intelligence (AI) in biopharmaceuticals market in the future. These are enduring health conditions that typically develop gradually and can last for extended periods or even a person’s entire life. Their emergence is linked to lifestyle choices, an older demographic, genetic susceptibilities, and environmental influences. Artificial intelligence in biopharmaceuticals finds increasing application in managing chronic diseases due to its capacity to analyze vast amounts of varied data, detect underlying patterns, and tailor therapeutic strategies. For example, data from November 2023 from the Department of Health and Human Services, a US-based government department, indicated an 11 percent rise in new chronic hepatitis B cases in 2022 compared to 2021. Consequently, the rising occurrence of chronic ailments acts as a significant catalyst for the growth of artificial intelligence (AI) in the biopharmaceuticals market.
What Are The Emerging Segments Gaining Attention In The Artificial Intelligence (AI) In Biopharmaceuticals Market?
The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –
1) By Offering: Hardware, Software, Services
2) By Deployment: Cloud, On-Premises
3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine
5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes
Subsegments:
1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions
3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services
What Trends Are Redefining The Artificial Intelligence (AI) In Biopharmaceuticals Market Dynamics?
Leading companies leveraging artificial intelligence (AI) in biopharmaceuticals are concentrating on creating pioneering advancements, such as AI-driven target and lead identification suite solutions, to accelerate drug discovery and precision medicine and, in turn, transform life sciences organizations. These solutions for drug discovery and precision medicine integrate diverse innovative methodologies for developing novel drugs and customizing treatments for individual patients. As an illustration, in May 2023, Google LLC, a US-based cloud computing service provider, unveiled two new AI-powered instruments, known as target and lead identification suites, intended to aid researchers in forecasting and deciphering protein structures, a foundational element of drug development. Furthermore, this suite will empower researchers to ingest, store, analyze, and share vast quantities of genomic data, which is vital for precision medicine. These tools are also designed to streamline the drug discovery process, minimize costs, and expedite the introduction of new treatments to the market. By offering efficient data management, precise predictions of protein structures, and sophisticated genomic analysis capabilities, these tools aspire to revolutionize drug development workflows and enhance patient outcomes.
Who Are The Top Performing Companies In The Artificial Intelligence (AI) In Biopharmaceuticals Market In Recent Years?
Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.
Download The Full Report For Exclusive Market Findings:
What Regional Growth Trends Are Shaping The Artificial Intelligence (AI) In Biopharmaceuticals Market Outlook?
North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Artificial Intelligence (AI) In Biopharmaceuticals Market Report:
https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2025, By The Business Research Company
Artificial Intelligence Ai In Agriculture Global Market Report 2025
Artificial Intelligence In Cancer Diagnostics Global Market Report 2025
Artificial Intelligence In Cardiology Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
